BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/25/2023 6:03:15 AM | Browse: 271 | Download: 1562
 |
Received |
|
2023-09-20 10:05 |
 |
Peer-Review Started |
|
2023-09-20 10:07 |
 |
First Decision by Editorial Office Director |
|
2023-10-25 13:28 |
 |
Return for Revision |
|
2023-10-25 13:28 |
 |
Revised |
|
2023-11-03 06:29 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2023-11-14 02:06 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2023-11-21 07:33 |
 |
Articles in Press |
|
2023-11-21 07:33 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-11-27 00:36 |
 |
Publish the Manuscript Online |
|
2023-12-25 06:03 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Virology |
| Manuscript Type |
Observational Study |
| Article Title |
Serum omentin-1 is correlated with the severity of liver disease in patients with chronic hepatitis C
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Georg Peschel, Kilian Weigand, Jonathan Grimm, Martina Müller and Christa Buechler |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Christa Buechler, PhD, Senior Researcher, Department of Internal Medicine I, University Hospital Regensburg, Franz-Josef-Strauss Allee 11, Regensburg 93053, Germany. christa.buechler@klinik.uni-regensburg.de |
| Key Words |
Direct acting antivirals; Hepatitis C; Liver cirrhosis; Adipokine |
| Core Tip |
Omentin-1 is an adipokine well described for its anti-inflammatory and insulin-sensitizing functions. Aim of this study was to identify the effect of hepatitis C virus (HCV) infection and liver cirrhosis on serum omentin-1 levels. This study showed that circulating omentin-1 levels of HCV infected patients and non-infected healthy controls were similar. Accordingly, serum omentin-1 levels did not change upon effective elimination of the virus by direct acting antiviral therapy. Serum omentin-1 was not associated with diabetes or C-reactive protein in the HCV cohort. Patients with liver cirrhosis had increased serum omentin-1 levels before treatment and at sustained virological response 12 in comparison to HCV patients without liver cirrhosis. This analysis shows that increased serum omentin-1 levels of chronic HCV patients with liver cirrhosis persists after viral elimination. Serum omentin-1 has no role in the favourable metabolic outcomes of HCV eradication. |
| Publish Date |
2023-12-25 06:03 |
| Citation |
Peschel G, Weigand K, Grimm J, Müller M, Buechler C. Serum omentin-1 is correlated with the severity of liver disease in patients with chronic hepatitis C. World J Hepatol 2023; 15(12): 1315-1324 |
| URL |
https://www.wjgnet.com/1948-5182/full/v15/i12/1315.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v15.i12.1315 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.